user

Overexpression of p53 in myelodysplastic syndromes: Correlation with FAB subtypes

被引：0
|
作者：
Wang, GS [1 ]
Shidham, V [1 ]
Kampalath, B [1 ]
机构：
[1] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 1999年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
82
引用
收藏
页码：559 / 560
页数：2
相关论文
共 50 条
  • [1] P53 MUTATION IN THE MYELODYSPLASTIC SYNDROMES
    ADAMSON, DJA
    DAWSON, AA
    BENNETT, B
    KING, DJ
    HAITES, NE
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) : 61 - 66
  • [2] P53 MUTATIONS IN MYELODYSPLASTIC SYNDROMES
    LUDWIG, L
    SCHULZ, AS
    JANSSEN, JWG
    GRUNEWALD, K
    BARTRAM, CR
    LEUKEMIA, 1992, 6 (12) : 1302 - 1304
  • [3] DETECTION OF SERUM ANTI P53 ANTIBODIES AND THEIR CORRELATION WITH P53 MUTATIONS IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID-LEUKEMIA
    PREUDHOMME, C
    LUBIN, R
    LEPELLEY, P
    VANRUMBEKE, M
    FENAUX, P
    LEUKEMIA, 1994, 8 (09) : 1589 - 1591
  • [4] Significance of P53 Immunostaining in the Diagnosis of Myelodysplastic Syndromes
    Taheri, Z. Mohammad
    Pournazari, P.
    Auer, I.
    Mansoor, A.
    Luider, J.
    Torbatian, M.
    Shabani-Rad, M-T
    LABORATORY INVESTIGATION, 2012, 92 : 356A - 356A
  • [5] Significance of P53 Immunostaining in the Diagnosis of Myelodysplastic Syndromes
    Taheri, Z. Mohammad
    Pournazari, P.
    Auer, I.
    Mansoor, A.
    Luider, J.
    Torbatian, M.
    Shabani-Rad, M-T
    MODERN PATHOLOGY, 2012, 25 : 356A - 356A
  • [6] De Novo Myelodysplastic Syndromes With Fibrosis Exhibit an Increased Frequency of TP53 Mutations and p53 Overexpression
    Loghavi, Sanam
    Al-Lbraheemi, Alyaa
    Zuo, Zhuang
    Wang, Sa
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Yin, C. Cameron
    Miranda, Roberto
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos
    Khoury, Joseph
    LABORATORY INVESTIGATION, 2015, 95 : 361A - 361A
  • [7] De Novo Myelodysplastic Syndromes With Fibrosis Exhibit an Increased Frequency of TP53 Mutations and p53 Overexpression
    Loghavi, Sanam
    Al-Ibraheemi, Alyaa
    Zuo, Zhuang
    Wang, Sa
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Yin, C. Cameron
    Miranda, Roberto
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos
    Khoury, Joseph
    MODERN PATHOLOGY, 2015, 28 : 361A - 361A
  • [8] Clinical Implications of p53 Dysfunction in Patients with Myelodysplastic Syndromes
    Riva, Elena
    Zampini, Matteo
    Alberto, Termanini
    Dall'Olio, Lorenzo
    Merlotti, Alessandra
    Kulasekararaj, Austin
    Calvi, Michela
    Di Vito, Clara
    Rahal, Daoud
    Bonometti, Arturo
    Croci, Giorgio
    Boveri, Emanuela
    Gianelli, Umberto
    Ponzoni, Maurilio
    Russo, Antonio
    Tinterri, Benedetta
    Re, Francesca
    Sauta, Elisabetta
    Saba, Elena
    Travaglino, Erica
    Ubezio, Marta
    Campagna, Alessia
    Lanino, Luca
    Maggioni, Giulia
    Tentori, Cristina Astrid
    Milanesi, Chiara
    Manes, Nicla
    D'Amico, Saverio
    Ficara, Francesca
    Crisafulli, Laura
    Mavilio, Domenico
    Lugli, Enrico
    Santoro, Armando
    Diez-Campelo, Maria
    Sanz, Guillermo
    Sole, Francesc
    Platzbecker, Uwe
    Santini, Valeria
    Kordasti, Shahram
    Fenaux, Pierre
    Haferlach, Torsten
    Remondini, Daniel
    Gastone, Castellani
    Della Porta, Matteo G.
    BLOOD, 2022, 140 : 4001 - 4004
  • [9] The proapoptotic protein SIVA, a target of p53, is downregulated in myelodysplastic syndromes
    Machado-Neto, J. A.
    De Melo Campos, P.
    Favaro, P.
    Lazarini, M.
    Lorand-Metze, I.
    Costa, F. F.
    Olalla Saad, S. T.
    Traina, F.
    LEUKEMIA RESEARCH, 2013, 37 : S31 - S31
  • [10] P53 Protein Overexpression By Immunohistochemical Staining Is Correlated with TP53 Mutation Burden and Adverse Clinical Outcome in Myelodysplastic Syndromes
    Johnny, Nguyen
    McGraw, Kathy L.
    Komrokji, Rami S.
    Sallman, David
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey E.
    Moscinski, Lynn C.
    List, Alan F.
    Zhang, Ling
    BLOOD, 2015, 126 (23)
12345